Drug Trial Radar · NCT00679965
Study of Different Doses of a Novel Treatment for Onychomycosis
Last checked: Nov 20, 2026Latest source record: Dec 12, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
159
Actual
Start
Feb 28, 2006
Primary completion
Jul 31, 2007
Study completion Jul 31, 2007
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- May 19, 2008
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to determine the safety and efficacy of 2.5%, 5.0%, and 7.5% AN2690 Solutions compared to the vehicle alone in the treatment of distal, subungual onychomycosis of the great target toenail.
Conditions
- Distal, Subungual Onychomycosis
Interventions
AN2690, 2.5%Drug
Once daily application for 90 days and 3 x weekly for 90 days
AN2690, 5%Drug
Once daily application for 90 days and 3 x weekly for 90 days
AN2690, 7.5%Drug
Once daily application for 90 days and 3 x weekly for 90 days
AN2690 Solution VehicleDrug
Once daily application for 90 days and 3x weekly for 90 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical evidence of complete great toenail clearance or at least fungal-clear great toenail growth ("complete" = 5mm; "partial" = 2mm), plus a negative fungal culture from the treatment-targeted great toenail.Time frame: Day 180
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
Unidad de Investigación en Salud (UIS)
Chihuahua City, Mexico
Hospital "Dr. Angel Leaño"
Guadalajara, Mexico
Instituto Dermatologico Jalisciense
Guadalajara, Mexico
Centro Dermatologico Pascua
Mexico City, Mexico
CIF-BIOTEC Medica Sur.
Mexico City, Mexico
IMIC
Mexico City, Mexico
Hospital Universitario Dr. José Eleuterio González
Monterrey, Mexico
MIRC / OCA Hospital
Monterrey, Mexico
ISSEMYM
Toluca, Mexico
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.